GZMB and ovarian carcinoma: In ovarian carcinoma, the expression of APOBEC3G was positively correlated with T cell infiltration, expression of cytotoxic granzyme and perforin (GZMB and PRF1), and improved clinical outcome (Leonard et al., 2016).